project id: TCGA-MESO; case submitter id: TCGA-ZN-A9VS; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 9.4; age at index: 67; days to birth: -24490; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1944; age at diagnosis: 24490; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1228.0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9052/3; primary diagnosis: Epithelioid mesothelioma, malignant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: No; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 772; initial weight: 60.0; sample id: 0c4efd25-9a31-404c-856d-7df587e99d60; sample submitter id: TCGA-ZN-A9VS-01A; portion id: ec6471ad-df2c-4cb4-9898-b9642c648cfe; portion submitter id: TCGA-ZN-A9VS-01A-11; slide id: 950616bb-ac32-4a7e-b95c-5bef8a95d1df; slide submitter id: TCGA-ZN-A9VS-01A-01-TS1; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0; section location: TOP;